Of all the ashwagandha side effects circulating on forums right now, thyroid interference is the one that surprises people most — because most wellness marketing doesn't mention it at all. Ashwagandha (Withania somnifera) has demonstrated the ability to increase circulating levels of T3 and T4 thyroid hormones in multiple human studies. For people with hypothyroidism who are already on levothyroxine or similar medications, this interaction can push thyroid levels outside of therapeutic range — potentially causing symptoms like heart palpitations, anxiety, insomnia, and unintended weight changes.

A 2017 study published in the Journal of Alternative and Complementary Medicine found that participants taking 600mg of ashwagandha root extract daily for eight weeks showed statistically significant increases in both T3 and T4 compared to placebo. While researchers framed this as potentially beneficial for subclinical hypothyroidism, the flip side is that anyone with hyperthyroidism, Graves' disease, or who takes thyroid medication should approach ashwagandha with real caution — ideally not at all without physician oversight.

The practical concern is this: thyroid dysfunction is often subtle and slow-moving. Someone might take ashwagandha for months before noticing that their anxiety has worsened or their sleep has fractured — symptoms they're attributing to stress, not supplementation. If you have any thyroid condition or family history of one, this is the ashwagandha side effect to take most seriously, and it's worth discussing with your doctor before you start any regimen involving this adaptogen.

This is the ashwagandha side effect that generated the most alarming headlines in 2024, and for good reason. A growing number of case reports — published in journals including Hepatology Communications and flagged by the World Health Organization's pharmacovigilance database — have documented drug-induced liver injury (DILI) linked to ashwagandha supplementation. The presentations range from elevated liver enzymes (a warning sign) to cholestatic hepatitis, and in rare cases, acute liver failure requiring hospitalization.

What makes this particularly tricky is that the mechanism isn't fully understood. Some researchers suspect withanolides — the bioactive compounds that give ashwagandha its adaptogenic properties — may be hepatotoxic in susceptible individuals, particularly at higher doses or with prolonged use. Others point to potential contamination in unregulated supplement supply chains, where heavy metals or undisclosed adulterants in poorly manufactured ashwagandha products may be responsible. The honest answer is: we don't know exactly who is at risk, and that uncertainty is the problem.

Clinically documented cases have involved both standardized root extract products and raw root powder, which rules out any simple "just use a better brand" fix. Most case reports involved adults taking between 300mg and 1,500mg daily — squarely within the typical supplemental dosing range — for periods ranging from a few weeks to several months. People with pre-existing liver conditions, alcohol use, or who take other potentially hepatotoxic medications (certain statins, NSAIDs, or antifungals) face meaningfully elevated risk. If you're currently taking ashwagandha and notice dark urine, jaundice, fatigue, or right-side abdominal discomfort, stop use and consult a physician promptly — these are early warning signs of liver stress.

This is also the context in which alternatives like Yes! The Total Cortisol Reset become worth discussing — saffron's safety profile in published human research has not produced comparable hepatotoxicity signals, which matters if you're someone who wants cortisol and mood support without the liver uncertainty.

This is the most common ashwagandha side effect and the one most frequently reported in clinical trials — which is at least a good sign that it's being tracked. Nausea, diarrhea, stomach cramping, and GI upset appear consistently in the adverse event logs of ashwagandha studies, particularly in trials using higher doses (600mg–1,200mg daily) or raw root powder rather than standardized extract. In some studies, GI complaints led to a meaningful percentage of participants discontinuing use entirely.

The leading theory is that ashwagandha's withanolide content irritates the gastric lining, especially when taken on an empty stomach. Most practitioners recommend taking ashwagandha with food for this reason. However, for people with irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), or baseline GI sensitivity, even food-accompanied dosing doesn't reliably prevent symptoms. Starting with a lower dose (150–300mg) and titrating up slowly is the conventional mitigation strategy, though it doesn't work for everyone.

It's also worth noting that the root powder form tends to produce more GI complaints than standardized root extract — if you're committed to ashwagandha, opting for a product standardized to a specific withanolide percentage (typically 5–10%) and manufactured under GMP certification is a more controlled starting point. That said, if your primary goal is reducing stress and cortisol reactivity rather than specifically needing ashwagandha, switching to a GI-friendlier formula may simply be the smarter path. Powder drink mixes can actually be easier on digestion than capsule-delivered botanical extracts, particularly at the doses involved.

Two less-discussed but clinically meaningful ashwagandha side effects deserve a combined entry: hormonal activity beyond the thyroid, and the risk of compounding sedation when combined with certain medications or substances.

On the hormonal side, ashwagandha has demonstrated androgenic activity — meaning it can influence testosterone and related hormone pathways. Studies in men have shown increases in serum testosterone and DHEA-S, which is sometimes marketed as a benefit. But for women with hormone-sensitive conditions — including certain estrogen-receptor-positive cancers, PCOS, or endometriosis — androgenic or steroidal activity from a supplement is a legitimate concern that should be reviewed with a physician before starting. Ashwagandha has also been flagged as potentially uterotonic, meaning it may stimulate uterine contractions, which is why it is contraindicated during pregnancy across most clinical guidance.

The sedation interaction risk is more immediately practical for a broader audience. Ashwagandha has GABAergic activity — it modulates GABA receptors in ways that produce calming effects. This is partly what makes it effective for anxiety. But it also means that combining ashwagandha with benzodiazepines, sleep aids, anticonvulsants, or alcohol can potentiate sedative effects in unpredictable ways. People who take any CNS-depressant medication and are also supplementing with ashwagandha are essentially stacking sedative mechanisms without clear dosing guidance for the combination. Reports of excessive drowsiness, cognitive slowing, and impaired coordination have emerged in this population.

The broader takeaway across all five of these ashwagandha side effects is that this is a genuinely bioactive compound with real physiological reach — which is exactly what makes it effective for some people and risky for others. If you're in a category where any of these risks apply, it's worth asking whether you need ashwagandha specifically, or whether you need what ashwagandha is supposed to deliver: lower cortisol reactivity, better mood, and sustainable daily energy. Those outcomes are addressable through mechanisms that don't carry these documented concerns.